Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Meta-analysis of Associations Between four Polymorphisms in the Matrix Metalloproteinases Gene and Gastric Cancer Risk

  • Yang, Teng-Fei (Department of Gastroenterology Surgery, Affiliated Shengjing Hospital of China Medical University) ;
  • Guo, Lin (Department of Gastroenterology Surgery, Affiliated Shengjing Hospital of China Medical University) ;
  • Wang, Qiang (Department of Gastroenterology Surgery, Affiliated Shengjing Hospital of China Medical University)
  • Published : 2014.02.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Matrix metalloproteinases (MMPs) play important roles in pathogenesis and development of cancer. Recently, many studies have show associations between polymorphisms in the promoter regions of MMPs and risk of gastric cancer. The present meta-analysis was conducted in order to investigate the potential association between four polymorphisms in the MMP gene and gastric cancer risk. Methods: A computerized literature search was conducted in databases of Med-line, Embase, Science Citation Index and PubMed till June 2013 for any MMP genetic association study of gastric cancer. Odds ratios (ORs) and 95 % confidence intervals (CIs) were estimated for each gene under dominant and recessive models, and heterogeneity between studies was assessed using the Q test and $I^2$ value. Overall and subgroup analyses according to ethnicity were carried out with Stata 12.0. Results: 14 reports covering 8,146 patients (2,980 in the case group and 5,166 in the control group) were included in the present meta-analysis. We found that the MMP-7 (-181A>G) polymorphism increased the gastric cancer risk in therecessive model (GG vs. AA/AG, OR=1.768, 95% CI =1.153-2.712). For MMP2 -1306 C>T, MMP1-1607 1G/2G, and MMP9-1 562 C>T, there were no associations between these polymorphisms and the risk of gastric cancer under dominant or recessive models. Conclusion: This meta-analysis suggested that the MMP7-181 A>G polymorphism may contribute to gastric cancer susceptibility. More studies are needed, especially in Europeans, in the future.

Keywords

References

  1. Alakus H, Afriani N, Warnecke-Eberz U, et al (2010). Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer. World J Surg, 34, 2853-59. https://doi.org/10.1007/s00268-010-0761-4
  2. Carneiro F, Huntsman D G, Smyrk T C, et al (2004). Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol, 203, 681-87. https://doi.org/10.1002/path.1564
  3. Companioni O, Bonet C, Munoz X, et al (2013). Polymorphisms of H. pylori signaling pathway genes and gastric cancer risk in the European EPIC-eurgast cohort. Int J Cancer, 134, 92-101.
  4. de Martel C, Ferlay J, Franceschi S, et al (2012). Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol, 13, 607-15. https://doi.org/10.1016/S1470-2045(12)70137-7
  5. Egeblad M, Werb Z (2002). New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer, 2, 161-74. https://doi.org/10.1038/nrc745
  6. Fingleton B, Vargo-Gogola T, Crawford H C, et al (2001). Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis. Neoplasia, 3, 459-68. https://doi.org/10.1038/sj.neo.7900190
  7. Hu C, Wang J, Xu Y, et al (2013). Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP). gene and lung cancer risk: a meta-analysis. Gene, 517, 65-71. https://doi.org/10.1016/j.gene.2012.12.085
  8. Jin X, Kuang G, Wei LZ, et al (2005). No association of the matrix metalloproteinase 1 promoter polymorphism with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in northern China. World J Gastroenterol, 11, 2385-89. https://doi.org/10.3748/wjg.v11.i16.2385
  9. Ke P, Wu ZD, Wen HS, et al (2013). Current evidence on associations between the MMP-7 (-181A>G). polymorphism and digestive system cancer risk. Asian Pac J Cancer Prev, 14, 2269-72. https://doi.org/10.7314/APJCP.2013.14.4.2269
  10. Kim J, Pyun J A, Cho S W, et al (2011). Lymph node metastasis of gastric cancer is associated with the interaction between poly (ADP-ribose). polymerase 1 and matrix metallopeptidase 2. Dna Cell Biol, 30, 1011-17. https://doi.org/10.1089/dna.2011.1250
  11. Kubben F J, Sier C F, Meijer M J, et al (2006). Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer. Br J Cancer, 95, 744-51. https://doi.org/10.1038/sj.bjc.6603307
  12. Lee Y Y, Derakhshan M H (2013). Environmental and lifestyle risk factors of gastric cancer. Arch Iran Med ,16, 358-65.
  13. Li X, Qu L, Zhong Y, et al (2013). Association between promoters polymorphisms of matrix metalloproteinases and risk of digestive cancers: a meta-analysis. J Cancer Res Clin Oncol, 139, 1433-47. https://doi.org/10.1007/s00432-013-1446-9
  14. Li Y, Sun DL, Duan YN, et al (2010). Association of functional polymorphisms in MMPs genes with gastric cardia adenocarcinoma and esophageal squamous cell carcinoma in high incidence region of North China. Mol Biol Rep, 37, 197-205. https://doi.org/10.1007/s11033-009-9593-4
  15. Lin X D, Chen G, Li C, et al (2011). Association of polymorphism in matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 with genetic susceptibility of gastric cancer. Zhonghua Yu Fang Yi Xue Za Zhi, 45, 711-16.
  16. Malik M A, Zargar S A, Mittal B (2011). Role of the metalloproteinase-7 (181A>G). polymorphism in gastric cancer susceptibility: a case control study in Kashmir valley. Asian Pac J Cancer Prev, 12, 73-76.
  17. Matsumura S, Oue N, Kitadai Y, et al (2004). A single nucleotide polymorphism in the MMP-1 promoter is correlated with histological differentiation of gastric cancer. J Cancer Res Clin Oncol, 130, 259-65. https://doi.org/10.1007/s00432-004-0543-1
  18. Matsumura S, Oue N, Nakayama H, et al (2005). A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer. J Cancer Res Clin Oncol, 131, 19-25. https://doi.org/10.1007/s00432-004-0621-4
  19. McColgan P, Sharma P (2009). Polymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects. Int J Cancer, 125, 1473-78. https://doi.org/10.1002/ijc.24441
  20. Miao X, Yu C, Tan W, et al (2003). A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T). is associated with risk of development but not metastasis of gastric cardia adenocarcinoma. Cancer Res, 63, 3987-90.
  21. Noe V, Fingleton B, Jacobs K, et al (2001). Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci, 114, 111-18.
  22. Peng B, Cao L, Ma X, et al (2010). Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk. Mutagenesis, 25, 371-79. https://doi.org/10.1093/mutage/geq015
  23. Price S J, Greaves D R, Watkins H (2001). Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem, 276, 7549-58. https://doi.org/10.1074/jbc.M010242200
  24. Rutter JL, Mitchell TI, Buttice G, et al (1998). A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res, 58, 5321-25.
  25. Sugimoto M, Furuta T, Kodaira C, et al (2008). Polymorphisms of matrix metalloproteinase-7 and chymase are associated with susceptibility to and progression of gastric cancer in Japan. J Gastroenterol, 43, 751-61. https://doi.org/10.1007/s00535-008-2221-6
  26. Wu CY, Wu MS, Chen YJ, et al (2007). Clinicopathological significance of MMP-2 and TIMP-2 genotypes in gastric cancer. Eur J Cancer, 43, 799-808. https://doi.org/10.1016/j.ejca.2006.10.022
  27. Zhang B, Ye S, Herrmann SM, et al (1999). Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation, 99, 1788-94. https://doi.org/10.1161/01.CIR.99.14.1788
  28. Zhang J, Jin X, Fang S, et al (2005). The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma. Carcinogenesis, 26, 1748-53. https://doi.org/10.1093/carcin/bgi144
  29. Zhang X M, Miao X P, Xiong P, et al (2004). Association of functional polymorphisms in matrix metalloproteinase-2 (MMP-2). and MMP-9 genes with risk of gastric cancer in a Chinese population. Ai Zheng, 23, 1233-37.
  30. Zhou P, Du LF, Lv GQ, et al (2011). Current evidence on the relationship between four polymorphisms in the matrix metalloproteinases (MMP). gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat, 127, 813-18. https://doi.org/10.1007/s10549-010-1294-0

Cited by

  1. Anti-Proliferation Effects and Molecular Mechanisms of Action of Tetramethypyrazine on Human SGC-7901 Gastric Carcinoma Cells vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3581
  2. Tanshinone IIA decreases the migratory ability of AGS cells by decreasing the protein expression of matrix metalloproteinases, nuclear factor κB-p65 and cyclooxygenase-2 vol.13, pp.2, 2015, https://doi.org/10.3892/mmr.2015.4658
  3. Risk Factors and Epidemiology of Gastric Cancer in Pakistan vol.16, pp.12, 2015, https://doi.org/10.7314/APJCP.2015.16.12.4821
  4. MMP2 Gene-735 C/T and MMP9 gene -1562 C/T Polymorphisms in JAK2V617F Positive Myeloproliferative Disorders vol.16, pp.2, 2015, https://doi.org/10.7314/APJCP.2015.16.2.443
  5. Association and Prognostic Significance of the Functional −1562C/T Polymorphism in the Promoter Region of MMP-9 in Turkish Patients with Gastric Cancer vol.21, pp.4, 2015, https://doi.org/10.1007/s12253-015-9950-7
  6. Role of allelic genes of matrix metalloproteinases and their tissue inhibitors in the risk of peptic ulcer disease development vol.52, pp.3, 2016, https://doi.org/10.1134/S1022795416020113
  7. Matrix metalloproteinase 9 gene polymorphisms are associated with a multiple family history of gastric cancer vol.20, pp.2, 2017, https://doi.org/10.1007/s10120-016-0608-2
  8. MMP1, 2, 3, 7, and 9 Gene Polymorphisms and Urinary Cancer Risk: A Meta-Analysis vol.19, pp.10, 2015, https://doi.org/10.1089/gtmb.2015.0123
  9. Prognostic value of gastric cancer-associated gene signatures: Evidence based on a meta-analysis using integrated bioinformatics methods pp.15821838, 2018, https://doi.org/10.1111/jcmm.13823